Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

103.800
-3.700-3.44%
Volume:17.01M
Turnover:1.76B
Market Cap:181.03B
PE:189.30
High:106.400
Open:104.300
Low:101.500
Close:107.500
52wk High:112.700
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.95
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:7.01%
ROA:2.10%
PB:7.48
PE(LYR):189.30
PS:9.88

Loading ...

Innovent Biologics - First Half 2026 Product Revenue Exceeds Rmb8.2 Bln, up over 55% Y/Y

THOMSON REUTERS
·
Aug 05

Movement Alert|INNOVENT BIO Declines 3.52% in Regular Trading, Trading at 83.5 HKD

Market Focus
·
Aug 03

Medtide Names Ding Lijun as CFO

Reuters
·
Jul 31

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Movement Alert|INNOVENT BIO Declines 3.12% in Regular Trading, Trading at 86.8 HKD

Market Focus
·
Jul 30

Obesity Specialty Standardized Weight Management Service System Initiative Launches in China

Deep News
·
Jul 26

Movement Alert|Innovent Biologics Rises 3.04% in Regular Trading, BD Deal Catalyst and Biotech Sector Recovery Drive Gains

Market Focus
·
Jul 20

Movement Alert|Innovent Biologics Falls 3.45% in Regular Trading, Trading at HK$89.85

Market Focus
·
Jul 17

Innovent Biologics (SEHK:1801) Is Up 9.1% After Striking US$1.10 Billion IBI355 Licensing Deal

Simply Wall St.
·
Jul 16

CLSA Raises Innovent Biologics Price Target to HK$139.9, Citing New Overseas Partnership

Stock News
·
Jul 16

Movement Alert|Innovent Biologics Falls 3.09% in Regular Trading, Trading at 94.4 HKD

Market Focus
·
Jul 16

Hong Kong Market Analysis: Longxun's IPO Valuation Sets Benchmark, Stirring Tech Sector; "Lab Monkey" Prices Drive CXO Surge

Stock News
·
Jul 15

Hong Kong Market Rises 1.4% on Fed Policy Shift Hopes; Healthcare and Consumer Stocks Lead Gains

Stock News
·
Jul 15

Innovent Biologics Shares Surge on Spero Deal That Could be Worth $1.1 Bln

Dow Jones
·
Jul 15

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Stock News
·
Jul 15

Innovent Biologics Shares Rise Over 3% on Exclusive Licensing Deal for IBI355 and Upcoming SjD Phase II Study

Stock News
·
Jul 15

Movement Alert|Innovent Biologics Rises 3.78% in Regular Trading, Exclusive Licensing Agreement with Spero Therapeutics for Third-Generation Anti-CD40L Antibody

Market Focus
·
Jul 15

Spero Licenses Innovent's Experimental Immune Disease Drug for up to $1.1 Billion

Reuters
·
Jul 14

Innovent Biologics Licenses Anti-cd40l Antibody Ibi355 to Spero in Deal Worth About USD 1.1 Billion

Reuters
·
Jul 14

Spero Therapeutics - Innovent to Receive Payments Totaling About $1.1 Bln Plus Tiered Royalties

THOMSON REUTERS
·
Jul 14